XML 54 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Organization and Nature of Operations (Details)
$ in Millions
 12 Months Ended 53 Months Ended
Dec. 31, 2024
productCandidate
Dec. 31, 2024
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Number of product candidates approved by the FDA 3  
Non-dilutive funding | $   $ 1,400.0
Number of proprietary product candidates advancing in clinical development 3